ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccine Conjugate Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-22Z8479
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccine Conjugate Market Insights Forecast to 2028
BUY CHAPTERS

Global Vaccine Conjugate Market Research Report 2025

Code: QYRE-Auto-22Z8479
Report
January 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Beijing Minhai Biotechnology
CanSinoBIO
Chengdu Olymvax Biopharmaceuticals
Beijing Xiangrui Biological Products

Vaccine Conjugate Market Size

The global market for Vaccine Conjugate was valued at US$ 10590 million in the year 2024 and is projected to reach a revised size of US$ 13250 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Vaccine Conjugate Market

Vaccine Conjugate Market

Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
North America is the largest supplier of Conjugate Vaccine, with a production market share nearly 65. Europe is the second largest supplier of Conjugate Vaccine, enjoying production market share nearly 26.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccine Conjugate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Conjugate.
The Vaccine Conjugate market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccine Conjugate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Conjugate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vaccine Conjugate Market Report

Report Metric Details
Report Name Vaccine Conjugate Market
Accounted market size in year US$ 10590 million
Forecasted market size in 2031 US$ 13250 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Children
  • Adult
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Bharat Biotech, Zhifei Biologic, Chengdu Olymvax Biopharmaceuticals, Beijing Minhai Biotechnology, CanSinoBIO, Beijing Xiangrui Biological Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vaccine Conjugate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vaccine Conjugate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Vaccine Conjugate Market growing?

Ans: The Vaccine Conjugate Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Vaccine Conjugate Market size in 2031?

Ans: The Vaccine Conjugate Market size in 2031 will be US$ 13250 million.

Who are the main players in the Vaccine Conjugate Market report?

Ans: The main players in the Vaccine Conjugate Market are Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Bharat Biotech, Zhifei Biologic, Chengdu Olymvax Biopharmaceuticals, Beijing Minhai Biotechnology, CanSinoBIO, Beijing Xiangrui Biological Products

What are the Application segmentation covered in the Vaccine Conjugate Market report?

Ans: The Applications covered in the Vaccine Conjugate Market report are Children, Adult

What are the Type segmentation covered in the Vaccine Conjugate Market report?

Ans: The Types covered in the Vaccine Conjugate Market report are Hib Vaccine, Meningococcal Vaccine, Pneumococcal Vaccine, Others

Recommended Reports

Vaccine Types

Pneumococcal/Conjugate Vaccines

Vaccine Delivery Chain

1 Vaccine Conjugate Market Overview
1.1 Product Definition
1.2 Vaccine Conjugate by Type
1.2.1 Global Vaccine Conjugate Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Vaccine Conjugate by Application
1.3.1 Global Vaccine Conjugate Market Value by Application (2024 VS 2031)
1.3.2 Children
1.3.3 Adult
1.4 Global Vaccine Conjugate Market Size Estimates and Forecasts
1.4.1 Global Vaccine Conjugate Revenue 2020-2031
1.4.2 Global Vaccine Conjugate Sales 2020-2031
1.4.3 Global Vaccine Conjugate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccine Conjugate Market Competition by Manufacturers
2.1 Global Vaccine Conjugate Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccine Conjugate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccine Conjugate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccine Conjugate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine Conjugate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine Conjugate, Product Type & Application
2.7 Global Key Manufacturers of Vaccine Conjugate, Date of Enter into This Industry
2.8 Global Vaccine Conjugate Market Competitive Situation and Trends
2.8.1 Global Vaccine Conjugate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccine Conjugate Players Market Share by Revenue
2.8.3 Global Vaccine Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccine Conjugate Market Scenario by Region
3.1 Global Vaccine Conjugate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccine Conjugate Sales by Region: 2020-2031
3.2.1 Global Vaccine Conjugate Sales by Region: 2020-2025
3.2.2 Global Vaccine Conjugate Sales by Region: 2026-2031
3.3 Global Vaccine Conjugate Revenue by Region: 2020-2031
3.3.1 Global Vaccine Conjugate Revenue by Region: 2020-2025
3.3.2 Global Vaccine Conjugate Revenue by Region: 2026-2031
3.4 North America Vaccine Conjugate Market Facts & Figures by Country
3.4.1 North America Vaccine Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccine Conjugate Sales by Country (2020-2031)
3.4.3 North America Vaccine Conjugate Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccine Conjugate Market Facts & Figures by Country
3.5.1 Europe Vaccine Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccine Conjugate Sales by Country (2020-2031)
3.5.3 Europe Vaccine Conjugate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Conjugate Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccine Conjugate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccine Conjugate Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccine Conjugate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccine Conjugate Market Facts & Figures by Country
3.7.1 Latin America Vaccine Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccine Conjugate Sales by Country (2020-2031)
3.7.3 Latin America Vaccine Conjugate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine Conjugate Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccine Conjugate Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccine Conjugate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vaccine Conjugate Sales by Type (2020-2031)
4.1.1 Global Vaccine Conjugate Sales by Type (2020-2025)
4.1.2 Global Vaccine Conjugate Sales by Type (2026-2031)
4.1.3 Global Vaccine Conjugate Sales Market Share by Type (2020-2031)
4.2 Global Vaccine Conjugate Revenue by Type (2020-2031)
4.2.1 Global Vaccine Conjugate Revenue by Type (2020-2025)
4.2.2 Global Vaccine Conjugate Revenue by Type (2026-2031)
4.2.3 Global Vaccine Conjugate Revenue Market Share by Type (2020-2031)
4.3 Global Vaccine Conjugate Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccine Conjugate Sales by Application (2020-2031)
5.1.1 Global Vaccine Conjugate Sales by Application (2020-2025)
5.1.2 Global Vaccine Conjugate Sales by Application (2026-2031)
5.1.3 Global Vaccine Conjugate Sales Market Share by Application (2020-2031)
5.2 Global Vaccine Conjugate Revenue by Application (2020-2031)
5.2.1 Global Vaccine Conjugate Revenue by Application (2020-2025)
5.2.2 Global Vaccine Conjugate Revenue by Application (2026-2031)
5.2.3 Global Vaccine Conjugate Revenue Market Share by Application (2020-2031)
5.3 Global Vaccine Conjugate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Vaccine Conjugate Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Vaccine Conjugate Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Vaccine Conjugate Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Vaccine Conjugate Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Company Information
6.5.2 Walvax Biotechnology Description and Business Overview
6.5.3 Walvax Biotechnology Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Walvax Biotechnology Vaccine Conjugate Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments/Updates
6.6 Royal (Wuxi) Bio-Pharmaceutical
6.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
6.6.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
6.6.3 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Product Portfolio
6.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
6.7 Bharat Biotech
6.7.1 Bharat Biotech Company Information
6.7.2 Bharat Biotech Description and Business Overview
6.7.3 Bharat Biotech Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bharat Biotech Vaccine Conjugate Product Portfolio
6.7.5 Bharat Biotech Recent Developments/Updates
6.8 Zhifei Biologic
6.8.1 Zhifei Biologic Company Information
6.8.2 Zhifei Biologic Description and Business Overview
6.8.3 Zhifei Biologic Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Zhifei Biologic Vaccine Conjugate Product Portfolio
6.8.5 Zhifei Biologic Recent Developments/Updates
6.9 Chengdu Olymvax Biopharmaceuticals
6.9.1 Chengdu Olymvax Biopharmaceuticals Company Information
6.9.2 Chengdu Olymvax Biopharmaceuticals Description and Business Overview
6.9.3 Chengdu Olymvax Biopharmaceuticals Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Chengdu Olymvax Biopharmaceuticals Vaccine Conjugate Product Portfolio
6.9.5 Chengdu Olymvax Biopharmaceuticals Recent Developments/Updates
6.10 Beijing Minhai Biotechnology
6.10.1 Beijing Minhai Biotechnology Company Information
6.10.2 Beijing Minhai Biotechnology Description and Business Overview
6.10.3 Beijing Minhai Biotechnology Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Beijing Minhai Biotechnology Vaccine Conjugate Product Portfolio
6.10.5 Beijing Minhai Biotechnology Recent Developments/Updates
6.11 CanSinoBIO
6.11.1 CanSinoBIO Company Information
6.11.2 CanSinoBIO Description and Business Overview
6.11.3 CanSinoBIO Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CanSinoBIO Vaccine Conjugate Product Portfolio
6.11.5 CanSinoBIO Recent Developments/Updates
6.12 Beijing Xiangrui Biological Products
6.12.1 Beijing Xiangrui Biological Products Company Information
6.12.2 Beijing Xiangrui Biological Products Description and Business Overview
6.12.3 Beijing Xiangrui Biological Products Vaccine Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Xiangrui Biological Products Vaccine Conjugate Product Portfolio
6.12.5 Beijing Xiangrui Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Conjugate Industry Chain Analysis
7.2 Vaccine Conjugate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Conjugate Production Mode & Process Analysis
7.4 Vaccine Conjugate Sales and Marketing
7.4.1 Vaccine Conjugate Sales Channels
7.4.2 Vaccine Conjugate Distributors
7.5 Vaccine Conjugate Customer Analysis
8 Vaccine Conjugate Market Dynamics
8.1 Vaccine Conjugate Industry Trends
8.2 Vaccine Conjugate Market Drivers
8.3 Vaccine Conjugate Market Challenges
8.4 Vaccine Conjugate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Beijing Minhai Biotechnology
CanSinoBIO
Chengdu Olymvax Biopharmaceuticals
Beijing Xiangrui Biological Products
List of Tables
 Table 1. Global Vaccine Conjugate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vaccine Conjugate Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vaccine Conjugate Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vaccine Conjugate Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Vaccine Conjugate Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vaccine Conjugate Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vaccine Conjugate Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vaccine Conjugate Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vaccine Conjugate, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vaccine Conjugate, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vaccine Conjugate, Product Type & Application
 Table 12. Global Key Manufacturers of Vaccine Conjugate, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vaccine Conjugate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Conjugate as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vaccine Conjugate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vaccine Conjugate Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Vaccine Conjugate Sales Market Share by Region (2020-2025)
 Table 19. Global Vaccine Conjugate Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Vaccine Conjugate Sales Market Share by Region (2026-2031)
 Table 21. Global Vaccine Conjugate Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vaccine Conjugate Revenue Market Share by Region (2020-2025)
 Table 23. Global Vaccine Conjugate Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vaccine Conjugate Revenue Market Share by Region (2026-2031)
 Table 25. North America Vaccine Conjugate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vaccine Conjugate Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Vaccine Conjugate Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Vaccine Conjugate Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vaccine Conjugate Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vaccine Conjugate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vaccine Conjugate Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Vaccine Conjugate Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Vaccine Conjugate Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vaccine Conjugate Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vaccine Conjugate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vaccine Conjugate Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Vaccine Conjugate Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Vaccine Conjugate Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vaccine Conjugate Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vaccine Conjugate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vaccine Conjugate Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Vaccine Conjugate Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Vaccine Conjugate Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vaccine Conjugate Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vaccine Conjugate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vaccine Conjugate Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Vaccine Conjugate Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Vaccine Conjugate Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vaccine Conjugate Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vaccine Conjugate Sales (K Doses) by Type (2020-2025)
 Table 51. Global Vaccine Conjugate Sales (K Doses) by Type (2026-2031)
 Table 52. Global Vaccine Conjugate Sales Market Share by Type (2020-2025)
 Table 53. Global Vaccine Conjugate Sales Market Share by Type (2026-2031)
 Table 54. Global Vaccine Conjugate Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vaccine Conjugate Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vaccine Conjugate Revenue Market Share by Type (2020-2025)
 Table 57. Global Vaccine Conjugate Revenue Market Share by Type (2026-2031)
 Table 58. Global Vaccine Conjugate Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Vaccine Conjugate Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Vaccine Conjugate Sales (K Doses) by Application (2020-2025)
 Table 61. Global Vaccine Conjugate Sales (K Doses) by Application (2026-2031)
 Table 62. Global Vaccine Conjugate Sales Market Share by Application (2020-2025)
 Table 63. Global Vaccine Conjugate Sales Market Share by Application (2026-2031)
 Table 64. Global Vaccine Conjugate Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vaccine Conjugate Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vaccine Conjugate Revenue Market Share by Application (2020-2025)
 Table 67. Global Vaccine Conjugate Revenue Market Share by Application (2026-2031)
 Table 68. Global Vaccine Conjugate Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Vaccine Conjugate Price (US$/Dose) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Pfizer Vaccine Conjugate Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. GSK Vaccine Conjugate Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Sanofi Vaccine Conjugate Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Merck Vaccine Conjugate Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Walvax Biotechnology Company Information
 Table 91. Walvax Biotechnology Description and Business Overview
 Table 92. Walvax Biotechnology Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Walvax Biotechnology Vaccine Conjugate Product
 Table 94. Walvax Biotechnology Recent Developments/Updates
 Table 95. Royal (Wuxi) Bio-Pharmaceutical Company Information
 Table 96. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
 Table 97. Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Product
 Table 99. Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
 Table 100. Bharat Biotech Company Information
 Table 101. Bharat Biotech Description and Business Overview
 Table 102. Bharat Biotech Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. Bharat Biotech Vaccine Conjugate Product
 Table 104. Bharat Biotech Recent Developments/Updates
 Table 105. Zhifei Biologic Company Information
 Table 106. Zhifei Biologic Description and Business Overview
 Table 107. Zhifei Biologic Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. Zhifei Biologic Vaccine Conjugate Product
 Table 109. Zhifei Biologic Recent Developments/Updates
 Table 110. Chengdu Olymvax Biopharmaceuticals Company Information
 Table 111. Chengdu Olymvax Biopharmaceuticals Description and Business Overview
 Table 112. Chengdu Olymvax Biopharmaceuticals Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. Chengdu Olymvax Biopharmaceuticals Vaccine Conjugate Product
 Table 114. Chengdu Olymvax Biopharmaceuticals Recent Developments/Updates
 Table 115. Beijing Minhai Biotechnology Company Information
 Table 116. Beijing Minhai Biotechnology Description and Business Overview
 Table 117. Beijing Minhai Biotechnology Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 118. Beijing Minhai Biotechnology Vaccine Conjugate Product
 Table 119. Beijing Minhai Biotechnology Recent Developments/Updates
 Table 120. CanSinoBIO Company Information
 Table 121. CanSinoBIO Description and Business Overview
 Table 122. CanSinoBIO Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 123. CanSinoBIO Vaccine Conjugate Product
 Table 124. CanSinoBIO Recent Developments/Updates
 Table 125. Beijing Xiangrui Biological Products Company Information
 Table 126. Beijing Xiangrui Biological Products Description and Business Overview
 Table 127. Beijing Xiangrui Biological Products Vaccine Conjugate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. Beijing Xiangrui Biological Products Vaccine Conjugate Product
 Table 129. Beijing Xiangrui Biological Products Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Vaccine Conjugate Distributors List
 Table 133. Vaccine Conjugate Customers List
 Table 134. Vaccine Conjugate Market Trends
 Table 135. Vaccine Conjugate Market Drivers
 Table 136. Vaccine Conjugate Market Challenges
 Table 137. Vaccine Conjugate Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vaccine Conjugate
 Figure 2. Global Vaccine Conjugate Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vaccine Conjugate Market Share by Type: 2024 & 2031
 Figure 4. Hib Vaccine Product Picture
 Figure 5. Meningococcal Vaccine Product Picture
 Figure 6. Pneumococcal Vaccine Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Vaccine Conjugate Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Vaccine Conjugate Market Share by Application: 2024 & 2031
 Figure 10. Children
 Figure 11. Adult
 Figure 12. Global Vaccine Conjugate Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Vaccine Conjugate Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Vaccine Conjugate Sales (2020-2031) & (K Doses)
 Figure 15. Global Vaccine Conjugate Average Price (US$/Dose) & (2020-2031)
 Figure 16. Vaccine Conjugate Report Years Considered
 Figure 17. Vaccine Conjugate Sales Share by Manufacturers in 2024
 Figure 18. Global Vaccine Conjugate Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Vaccine Conjugate Players: Market Share by Revenue in Vaccine Conjugate in 2024
 Figure 20. Vaccine Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Vaccine Conjugate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Vaccine Conjugate Sales Market Share by Country (2020-2031)
 Figure 23. North America Vaccine Conjugate Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Vaccine Conjugate Sales Market Share by Country (2020-2031)
 Figure 27. Europe Vaccine Conjugate Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Vaccine Conjugate Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Vaccine Conjugate Revenue Market Share by Region (2020-2031)
 Figure 35. China Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Vaccine Conjugate Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Vaccine Conjugate Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Vaccine Conjugate Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Vaccine Conjugate Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Vaccine Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Vaccine Conjugate by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Vaccine Conjugate by Type (2020-2031)
 Figure 57. Global Vaccine Conjugate Price (US$/Dose) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Vaccine Conjugate by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Vaccine Conjugate by Application (2020-2031)
 Figure 60. Global Vaccine Conjugate Price (US$/Dose) by Application (2020-2031)
 Figure 61. Vaccine Conjugate Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Veterinary Vaccination Market Research Report 2025
Global Livestock Animal Vaccines Market Research Report 2024
Veterinary Vaccine Market
Global Travelers Vaccines Market Research Report 2025
Global Livestock Animal Vaccination Market Research Report 2025
Global Travelers Vaccination Market Research Report 2025
Global Veterinary Biological Vaccines Market Research Report 2025
Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Vaccines Market Research Report 2025
Vaccine for Non infectious Meningitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bacterial Vaccines for Humans Market Research Report 2024
Global Peptide Carrier Protein Conjugates Market Research Report 2024
Global Human Vaccination Market Research Report 2025
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Livestock Vaccines Market Research Report 2025
Global Vaccinations Solutions for Pets Market Research Report 2025
Global Viral Vector Vaccine for Humans Market Research Report 2024
Ruminant Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Carriers Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions